×
U.S Physical Therapy SG&A Expenses 2010-2024 | USPH
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
U.S Physical Therapy sg&a expenses from 2010 to 2024. Sg&a expenses can be defined as the sum of all selling, general and administrative expenses.
View More
U.S Physical Therapy SG&A Expenses 2010-2024 | USPH
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
U.S Physical Therapy sg&a expenses from 2010 to 2024. Sg&a expenses can be defined as the sum of all selling, general and administrative expenses.
Related Stocks
Company Name
Market
Cap
Fresenius SE (FSNUY)
$21.4B
Quest Diagnostics (DGX)
$17.3B
DaVita (DVA)
$13.8B
Encompass Health (EHC)
$9.2B
Chemed (CHE)
$8.7B
Elanco Animal Health (ELAN)
$7.1B
Option Care Health (OPCH)
$5.3B
RadNet (RDNT)
$4.9B
Amedisys (AMED)
$3.2B
Astrana Health (ASTH)
$2.7B
LifeStance Health (LFST)
$2.6B
Addus HomeCare (ADUS)
$2.4B
Pennant (PNTG)
$1B
Aveanna Healthcare Holdings (AVAH)
$1B
Atai Life Sciences (ATAI)
$215M
Daxor (DXR)
$46M
ATI Physical Therapy (ATIP)
$26M
MEDIROM Healthcare Technologies (MRM)
$19M
Psychemedics (PMD)
$14M
Ontrak (OTRK)
$10M
Novo Integrated Sciences (NVOS)
$5M
IMAC Holdings (BACK)
$2M